Screener
Utah Medical Products UTMD Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| —— | —— | $512.75K+7.9% | $512.75K+7.9% | $512.75K+7.9% | ||
| —— | —— | $1.97M+0.6% | $1.97M+0.6% | $1.97M+0.6% | ||
| $637K-0.5% | $617K-12.5% | -$2.16M+19.8% | $698K-16.5% | $640K-17.2% | ||
| $2.69M-11.9% | $2.6M-14.4% | $2.57M-11.6% | $2.63M-26.2% | $3.05M-11.7% | ||
| $0.84-10.6% | $0.82-10.9% | $0.80-7.0% | $0.82-20.4% | $0.94-4.1% | ||
| $2.88M-27.0% | $3.24M-16.2% | $3.19M-12.6% | $3.37M-17.3% | $3.94M-4.3% | ||
| $2.65M-17.1% | $2.57M-18.6% | $2.44M-16.7% | $2.61M-21.9% | $3.2M-7.0% |
FAQ
- What is Utah Medical Products's revenue?
- Utah Medical Products (UTMD) generated $36.1M in revenue over the trailing twelve months, down 7.0% year over year.
- Is Utah Medical Products profitable?
- Utah Medical Products reported $10.5M in net income over the trailing twelve months, a 29.0% net margin.
- What are Utah Medical Products's profit margins?
- Gross margin is 57.9% and operating margin is 28.4%, with a 29.0% net margin.
- What is Utah Medical Products's earnings per share?
- Utah Medical Products's diluted EPS over the trailing twelve months is $3.28.
- Where does Utah Medical Products's income statement data come from?
- Every line is extracted from Utah Medical Products's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
